Epigenetic Regulation of Amyloid-beta Metabolism in Alzheimer’s Disease

被引:0
|
作者
Chuan He
Zhong-sheng Huang
Chao-chao Yu
Hai-hua Wang
Hua Zhou
Li-hong Kong
机构
[1] Hubei University of Chinese Medicine,Department of Tuina
[2] Shenzhen Traditional Chinese Medicine Hospital,undefined
[3] The 4th Clinical College of Guangzhou University of Chinese Medicine,undefined
[4] Hospital of Traditional Chinese Medicine of Fengrun District,undefined
来源
Current Medical Science | 2020年 / 40卷
关键词
Alzheimer’s disease; amyloid-β; epigenetics; DNA methylation; microRNAs; histone modifications;
D O I
暂无
中图分类号
学科分类号
摘要
Senile plaques (SPs) are one of the pathological features of Alzheimer’s disease (AD) and they are formed by the overproduction and aggregation of amyloid-beta (Aβ) peptides derived from the abnormal cleavage of amyloid precursor protein (APP). Thus, understanding the regulatory mechanisms during Aβ metabolism is of great importance to elucidate AD pathogenesis. Recent studies have shown that epigenetic modulation—including DNA methylation, non-coding RNA alterations, and histone modifications—is of great significance in regulating Aβ metabolism. In this article, we review the aberrant epigenetic regulation of Aβ metabolism.
引用
收藏
页码:1022 / 1030
页数:8
相关论文
共 50 条
  • [1] Epigenetic Regulation of Amyloid-beta Metabolism in Alzheimer's Disease
    He, Chuan
    Huang, Zhong-sheng
    Yu, Chao-chao
    Wang, Hai-hua
    Zhou, Hua
    Kong, Li-hong
    [J]. CURRENT MEDICAL SCIENCE, 2020, 40 (06) : 1022 - 1030
  • [2] Microbleeds relate to altered amyloid-beta metabolism in Alzheimer's disease
    Goos, Jeroen D. C.
    Teunissen, Charlotte E.
    Veerhuis, Robert
    Verwey, Nicolaas A.
    Barkhof, Frederik
    Blankenstein, Marinus A.
    Scheltens, Philip
    van der Flier, Wiesje M.
    [J]. NEUROBIOLOGY OF AGING, 2012, 33 (05) : 1011.e1 - 1011.e9
  • [3] Lifelong Management of Amyloid-Beta Metabolism to Prevent Alzheimer's Disease
    Gandy, Sam
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (09): : 864 - 866
  • [4] Presenilins, amyloid-beta and Alzheimer's disease
    Lamb, BT
    [J]. NATURE MEDICINE, 1997, 3 (01) : 28 - 29
  • [5] Amyloid-beta and Alzheimer's disease: the role of neprilysin-2 in amyloid-beta clearance
    Marr, Robert A.
    Hafez, Daniel M.
    [J]. FRONTIERS IN AGING NEUROSCIENCE, 2014, 6
  • [6] Alzheimer's disease - The ins and outs of amyloid-beta
    Beyreuther, K
    Masters, CL
    [J]. NATURE, 1997, 389 (6652) : 677 - 678
  • [7] Amyloid-Beta Solubility in the Treatment of Alzheimer's Disease
    Murphy, M. Paul
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (04): : 391 - 392
  • [8] Amyloid-Beta: A Crucial Factor in Alzheimer's Disease
    Sadigh-Eteghad, Saeed
    Sabermarouf, Babak
    Majdi, Alireza
    Talebi, Mahnaz
    Farhoudi, Mehdi
    Mahmoudi, Javad
    [J]. MEDICAL PRINCIPLES AND PRACTICE, 2015, 24 (01) : 1 - 10
  • [9] Chylomicron amyloid-beta in the aetiology of Alzheimer's disease
    Takechi, R.
    Galloway, S.
    Pallebage-Gamarallage, M. M. S.
    Mamo, J. C. L.
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (02) : 19 - 25
  • [10] Editorial on,"Amyloid-beta clearance in Alzheimer's disease"
    Marr, Robert A.
    [J]. FRONTIERS IN AGING NEUROSCIENCE, 2014, 6